344 related articles for article (PubMed ID: 30056066)
1. A systematic review comparing outcomes of surgical resection and non-surgical treatments for patients with hepatocellular carcinoma and portal vein tumor thrombus.
Liang L; Chen TH; Li C; Xing H; Han J; Wang MD; Zhang H; Lau WY; Wu MC; Shen F; Yang T
HPB (Oxford); 2018 Dec; 20(12):1119-1129. PubMed ID: 30056066
[TBL] [Abstract][Full Text] [Related]
2. Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.
Zhang XP; Wang K; Li N; Zhong CQ; Wei XB; Cheng YQ; Gao YZ; Wang H; Cheng SQ
BMC Cancer; 2017 Dec; 17(1):902. PubMed ID: 29282010
[TBL] [Abstract][Full Text] [Related]
3. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
4. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.
Ye HH; Ye JZ; Xie ZB; Peng YC; Chen J; Ma L; Bai T; Chen JZ; Lu Z; Qin HG; Xiang BD; Li LQ
World J Gastroenterol; 2016 Apr; 22(13):3632-43. PubMed ID: 27053855
[TBL] [Abstract][Full Text] [Related]
6. Better surgical treatment method for hepatocellular carcinoma with portal vein tumor thrombus.
Peng SY; Wang XA; Huang CY; Li JT; Hong DF; Wang YF; Xu B
World J Gastroenterol; 2018 Oct; 24(40):4527-4535. PubMed ID: 30386102
[TBL] [Abstract][Full Text] [Related]
7. Thrombocytopenia: A prognostic factor for hepatocellular carcinoma patients with portal vein tumor thrombus after hepatectomy.
Cheng YQ; Wang K; Zhang XP; Wei XB; Jiang YB; Hu YR; Mao FF; Guo WX; Shi J; Cheng SQ
J Gastroenterol Hepatol; 2019 Jul; 34(7):1214-1221. PubMed ID: 30402968
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive treatments for hepatocellular carcinoma with portal vein tumor thrombosis.
Wang JC; Xia AL; Xu Y; Lu XJ
J Cell Physiol; 2019 Feb; 234(2):1062-1070. PubMed ID: 30256409
[TBL] [Abstract][Full Text] [Related]
9. Resection might be a meaningful choice for hepatocellular carcinoma with portal vein thrombosis: A systematic review and meta-analysis.
Zhang ZY; Dong KS; Zhang EL; Zhang LW; Chen XP; Dong HH
Medicine (Baltimore); 2019 Dec; 98(50):e18362. PubMed ID: 31852141
[TBL] [Abstract][Full Text] [Related]
10. Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus.
Shi J; Lai EC; Li N; Guo WX; Xue J; Lau WY; Wu MC; Cheng SQ
Ann Surg Oncol; 2010 Aug; 17(8):2073-80. PubMed ID: 20131013
[TBL] [Abstract][Full Text] [Related]
11. Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?
Mähringer-Kunz A; Steinle V; Düber C; Weinmann A; Koch S; Schmidtmann I; Schotten S; Hinrichs JB; Graafen D; Pinto Dos Santos D; Galle PR; Kloeckner R
Liver Int; 2019 Feb; 39(2):324-331. PubMed ID: 30318826
[TBL] [Abstract][Full Text] [Related]
12. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
[TBL] [Abstract][Full Text] [Related]
13. Experience With LDLT in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis Postdownstaging.
Soin AS; Bhangui P; Kataria T; Baijal SS; Piplani T; Gautam D; Choudhary NS; Thiagarajan S; Rastogi A; Saraf N; Saigal S
Transplantation; 2020 Nov; 104(11):2334-2345. PubMed ID: 32032291
[TBL] [Abstract][Full Text] [Related]
14. Comparison of chemoembolization with and without radiation therapy and sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis.
Kim GA; Shim JH; Yoon SM; Jung J; Kim JH; Ryu MH; Ryoo BY; Kang YK; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
J Vasc Interv Radiol; 2015 Mar; 26(3):320-9.e6. PubMed ID: 25612807
[TBL] [Abstract][Full Text] [Related]
15. Curative Analysis of Several Therapeutic Methods for Primary Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Tang ZY; Zhou BH; Wang W; Du G; Liu ZY; Li J; Zhang SZ; Fu ZH
Hepatogastroenterology; 2015 May; 62(139):703-9. PubMed ID: 26897958
[TBL] [Abstract][Full Text] [Related]
16. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis.
Liu BJ; Gao S; Zhu X; Guo JH; Kou FX; Liu SX; Zhang X; Wang XD; Cao G; Chen H; Liu P; Zhu LZ; Xu HF; Yang RJ
Biomed Res Int; 2021; 2021():6670367. PubMed ID: 34337041
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification.
Xu JF; Liu XY; Wang S; Wen HX
World J Surg Oncol; 2015 Feb; 13():86. PubMed ID: 25889711
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study.
Zhang YF; Guo RP; Zou RH; Shen JX; Wei W; Li SH; OuYang HY; Zhu HB; Xu L; Lao XM; Shi M
Eur Radiol; 2016 Jul; 26(7):2078-88. PubMed ID: 26396105
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma with main portal vein tumor thrombus: a comparative study comparing hepatectomy with or without neoadjuvant radiotherapy.
Li N; Feng S; Xue J; Wei XB; Shi J; Guo WX; Lau WY; Wu MC; Cheng SQ; Meng Y
HPB (Oxford); 2016 Jun; 18(6):549-56. PubMed ID: 27317960
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
